129 related articles for article (PubMed ID: 9536925)
1. Angiotensin-converting enzyme inhibition does not correct early defects in renal and vascular permeability in diabetes mellitus.
Zietse R; Derkx FH; Weimar W; Schalekamp MA
Clin Sci (Lond); 1998 Feb; 94(2):165-73. PubMed ID: 9536925
[TBL] [Abstract][Full Text] [Related]
2. Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Vervoort G; Hertenberg F; Wetzels JF; Smits P
J Hypertens; 1998 Feb; 16(2):245-50. PubMed ID: 9535153
[TBL] [Abstract][Full Text] [Related]
3. Effect of atrial natriuretic peptide on renal and vascular permeability in diabetes mellitus.
Zietse R; Derkx FH; Weimar W; Schalekamp MA
J Am Soc Nephrol; 1995 Jun; 5(12):2057-66. PubMed ID: 7579054
[TBL] [Abstract][Full Text] [Related]
4. Effects of a dual inhibitor of angiotensin converting enzyme and neutral endopeptidase, MDL 100,240, on endocrine and renal functions in healthy volunteers.
Rousso P; Buclin T; Nussberger J; Décosterd LA; La Roche SD; Brunner-Ferber F; Brunner HR; Biollaz J
J Hypertens; 1999 Mar; 17(3):427-37. PubMed ID: 10100082
[TBL] [Abstract][Full Text] [Related]
5. Effects of angiotensin converting enzyme inhibitors and calcium antagonists on atrial natriuretic peptide release and action and on albumin excretion rate in hypertensive insulin-dependent diabetic patients.
Fioretto P; Frigato F; Velussi M; Riva F; Muollo B; Carraro A; Brocco E; Cipollina MR; Abaterusso C; Trevisan M
Am J Hypertens; 1992 Nov; 5(11):837-46. PubMed ID: 1457087
[TBL] [Abstract][Full Text] [Related]
6. Renal and adrenal resistance against atrial natriuretic peptide in congestive heart failure: effect of angiotensin I-converting-enzyme inhibition.
Wambach G; Schittenhelm U; Bönner G; Kaufmann W
Cardiology; 1989; 76(6):418-27. PubMed ID: 2558792
[TBL] [Abstract][Full Text] [Related]
7. Renal effects of atrial natriuretic factor during control of the renin-angiotensin system in anesthetized dogs.
Seymour AA; Mazack EK
Circ Res; 1988 Mar; 62(3):506-14. PubMed ID: 2830044
[TBL] [Abstract][Full Text] [Related]
8. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure.
Abassi Z; Haramati A; Hoffman A; Burnett JC; Winaver J
Am J Physiol; 1990 Jul; 259(1 Pt 2):R84-9. PubMed ID: 2142862
[TBL] [Abstract][Full Text] [Related]
9. Contrasting effects of angiotensin converting inhibitor and alpha-1-antagonist on albuminuria in insulin-dependent diabetes mellitus patients with nephropathy.
Holdaas H; Hartmann A; Berg KJ; Langberg H; Blystad L; Fauchald P
J Intern Med; 1995 Jan; 237(1):63-71. PubMed ID: 7830033
[TBL] [Abstract][Full Text] [Related]
10. Low-dose angiotensin converting enzyme inhibitors: effect on renal function in normo- and hypertensive type 1 diabetic patients.
Ciavarella A; Mustacchio A; Silletti A; Franchi R; Levorato M; Campieri C; Borgnino LC; Capozzi G; Morotti L; Vannini P
Eur J Med; 1992 Sep; 1(5):268-72. PubMed ID: 1341608
[TBL] [Abstract][Full Text] [Related]
11. Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.
Tikkanen I; Tikkanen T; Cao Z; Allen TJ; Davis BJ; Lassila M; Casley D; Johnston CI; Burrell LM; Cooper ME
J Hypertens; 2002 Apr; 20(4):707-14. PubMed ID: 11910307
[TBL] [Abstract][Full Text] [Related]
12. Short-term treatment with ramipril normalizes renal haemodynamics and the natriuretic response to a sodium load in type 1 diabetic patients with early nephropathy.
Stenvinkel P; Bolinder J; Alvestrand A
Acta Diabetol; 1997 Mar; 34(1):10-7. PubMed ID: 9134051
[TBL] [Abstract][Full Text] [Related]
13. Norepinephrine-induced blood pressure rise and renal vasoconstriction are not attenuated by enalapril treatment in microalbuminuric IDDM.
Hoogenberg K; Navis G; Dullaart RP
Nephrol Dial Transplant; 1998 Mar; 13(3):640-5. PubMed ID: 9550640
[TBL] [Abstract][Full Text] [Related]
14. Capillary permeability is increased in normo- and microalbuminuric type 1 diabetic patients: amelioration by ACE-inhibition.
Oomen PH; Jager J; Hoogenberg K; Dullaart RP; Reitsma WD; Smit AJ
Eur J Clin Invest; 1999 Dec; 29(12):1035-40. PubMed ID: 10583451
[TBL] [Abstract][Full Text] [Related]
15. WITHDRAWN: Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2007 Jul; (1):CD002183. PubMed ID: 17636698
[TBL] [Abstract][Full Text] [Related]
16. Effects of atrial natriuretic peptide infusion on kidney function in normotensive type 1 (insulin-dependent) diabetic patients before and after enalapril treatment.
Trevisan R; Giorato C; Fioretto P; Orrasch M; Opocher G; Mantero F; Tiengo A; Nosadini R; Pica B; Antonini P
J Hypertens Suppl; 1991 Dec; 9(6):S390-1. PubMed ID: 1840200
[No Abstract] [Full Text] [Related]
17. Angiotensin-converting enzyme inhibition by quinapril blocks the albuminuric effect of atrial natriuretic peptide in Type 1 diabetes and microalbuminuria.
McKenna K; Smith D; Barrett P; Glenn A; Kesson CM; Connell J; Thompson CJ
Diabet Med; 2000 Mar; 17(3):219-24. PubMed ID: 10784227
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2000; (2):CD002183. PubMed ID: 10796871
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin converting enzyme inhibitors in normotensive diabetic patients with microalbuminuria.
Lovell HG
Cochrane Database Syst Rev; 2001; (1):CD002183. PubMed ID: 11279757
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor-alpha gene expression in diabetic nephropathy: relationship with urinary albumin excretion and effect of angiotensin-converting enzyme inhibition.
Navarro JF; Milena FJ; Mora C; León C; Claverie F; Flores C; García J
Kidney Int Suppl; 2005 Dec; (99):S98-102. PubMed ID: 16336586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
